Plasma biomarkers are associated with agitation and regional brain atrophy in Alzheimer's disease

Jung Lung Hsu, Wei Ju Lee, Yi Chu Liao, Jiing Feng Lirng, Shuu Jiun Wang*, Jong Ling Fuh

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


This study investigated the relationships among plasma biomarkers, regional brain atrophy, and clinical symptoms in patients with Alzheimer's disease (AD; n = 177), mild cognitive impairment (MCI; N = 60) and controls (n = 108). The Mini-Mental Status Examination (MMSE), Clinical Dementia Rating (CDR), and Neuropsychiatric Inventory (NPI) subscales were administered to subjects. Magnetic resonance imaging was performed and medial temporal atrophy (MTA) and posterior atrophy (PA) were assessed visually. We examined associations among cognition, NPI score, plasma β-amyloid (Aβ) and clusterin levels, and regional brain atrophy in patients with AD by regression analysis. The mean MTA score was associated with the plasma Aβ1-42/Aβ1-40 ratio (r = 0.38, p = 0.01) and with MMSE scores (r = 0.43, p < 0.01). The plasma clusterin level was correlated with CDR sum of box and right-side PA scores (r = 0.28, p = 0.01 and r = 0.30, p = 0.03, respectively). Right-side PA scores were correlated significantly with NPI agitation/aggression (r = 0.30, p = 0.03) subscale scores. In conclusion, the plasma ratio of Aβ1-42/Aβ1-40 and clusterin level may be associated with different patterns of regional brain atrophy, which in turn may account for the clinical symptoms in patients with AD.

Original languageEnglish
Article number5035
JournalScientific reports
Issue number1
StatePublished - 1 Dec 2017


Dive into the research topics of 'Plasma biomarkers are associated with agitation and regional brain atrophy in Alzheimer's disease'. Together they form a unique fingerprint.

Cite this